New non-anticoagulant heparin derivatives

Details New non-anticoagulant heparin derivatives New non-anticoagulant heparin derivatives

C - Chemistry, Metallurgy

08

B

C08B 37/10 (2006.01) A61K 39/395 (2006.01) C07K 16/18 (2006.01) C08B 37/00 (2006.01) C12P 21/08 (2006.01) A61K 31/725 (1990.01)

Patent

CA 2107365

2107365 9217188 PCTABS00016 A non-anticoagulant (NAC) form of heparin which shows antiproliferative activity with respect to smooth muscle cells is useful in the prevention of restenosis and other conditions benefited by antiproliferative activity with respect to smooth muscle cells. This NAC form of heparin is prepared by deacetylating and then oxidizing heparin/heparan sulfate substantially to completion with periodate followed by reduction of the resulting aldehyde groups under conditions which prevent depolymerization of the heparin.

Affiliated with

Also associated with

Rating

New non-anticoagulant heparin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New non-anticoagulant heparin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New non-anticoagulant heparin derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2020862